Science & Enterprise subscription

Follow us on Twitter

  • Exclusive to Science & Enterprise ... An organization for redressing health disparities faced by women awarded a ne… https://t.co/nzlQAjGIZf
    about 5 hours ago
  • Exclusive to Science and Enterprise: Women’s Heart Health Diagnostics in the Works https://t.co/0rrQ5NLaDH #Science… https://t.co/fYwYiGHJhf
    about 5 hours ago
  • A new company, spun off from university biomedical engineering labs, is creating cancer diagnostics by analyzing mi… https://t.co/XvwdRSaAqJ
    about 22 hours ago
  • New post on Science and Enterprise: Start-Up Developing Microbial Cancer Detection Tests https://t.co/jJyKDfFQPz #Science #Business
    about 22 hours ago
  • An NIH award to a biotechnology company funds discovery of drugs that protect brain cells from degenerative disorde… https://t.co/kw5ISn5tuD
    about 1 day ago

Please share Science & Enterprise

Grant Funds Placenta Stem Cell Trial Sites for Covid-19

Pregnant woman

A clinical trial testing stem cells from human placentas as a treatment for Covid-19 infections is expanding to three more sites in California. . . . → Read More: Grant Funds Placenta Stem Cell Trial Sites for Covid-19

Trial to Test Stem Cells for Covid-19 Prevention

SARS-Cov-2 virus

A company that collects and stores a person’s own stem cells for therapies later on says FDA cleared a clinical trial of donated stem cells to prevent Covid-19 infections. . . . → Read More: Trial to Test Stem Cells for Covid-19 Prevention

Gene, Cell Therapy Start-Up Gains $700M in Early Funds

Stem cells

A biotechnology company creating engineered cells with modified genes for treating disease is raising $700 million in its first venture finance round. . . . → Read More: Gene, Cell Therapy Start-Up Gains $700M in Early Funds

Engineered Immune, Stem Cells Studied for HIV Cure

HIV released from cell

Academic and industry researchers are investigating engineered immune-system cells combined with stem cells as an immunotherapy to neutralize HIV viruses and cure infections. . . . → Read More: Engineered Immune, Stem Cells Studied for HIV Cure

Biotechs Partner on Crispr for Stem Cell Transplants

Editing DNA

A biotechnology partnership is evaluating a synthetic antibody to make it safer for people with genetic diseases to receive gene-edited bone marrow stem-cell transplants. . . . → Read More: Biotechs Partner on Crispr for Stem Cell Transplants

Foundations Back ALS Biomarker Study

Neuron

Two organizations supporting research on amyotrophic lateral sclerosis or ALS are funding a study of changes to chemical indicators in the body responding to ALS drugs. . . . → Read More: Foundations Back ALS Biomarker Study

Stem Cell Therapy Licensed for Genetic Eye Disease

Red-blue-green eye

A biotechnology company is licensing its stem cell treatments for retinitis pigmentosa, an inherited eye disease, in a deal valued at $252 million. . . . → Read More: Stem Cell Therapy Licensed for Genetic Eye Disease

Retina Implant, Stem Cell Studies Set for Space Station

International Space Station

A company providing laboratory modules for biomedical research on the International Space Station received funding from NASA for three new projects. . . . → Read More: Retina Implant, Stem Cell Studies Set for Space Station

Enrollment Completed in Aging Frailty Stem Cell Trial

Hands of older person

A company developing stem cell treatments to counter frailty in older people finished enlisting participants in a clinical trial testing its therapies. . . . → Read More: Enrollment Completed in Aging Frailty Stem Cell Trial

Blood Cancers Respond to Cord Blood Cells

Katy Rezvani

A small-scale clinical trial shows most patients with two blood-related cancers safely respond to immune system cells derived from umbilical cord blood. . . . → Read More: Blood Cancers Respond to Cord Blood Cells